nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—BCHE—Triamcinolone—psoriasis	0.12	0.262	CbGbCtD
Galantamine—CYP2D6—Hydroxyurea—psoriasis	0.0548	0.119	CbGbCtD
Galantamine—CYP3A4—Calcitriol—psoriasis	0.041	0.0893	CbGbCtD
Galantamine—CYP2D6—Cholecalciferol—psoriasis	0.0332	0.0724	CbGbCtD
Galantamine—CYP3A4—Methoxsalen—psoriasis	0.0319	0.0695	CbGbCtD
Galantamine—CYP2D6—Cyclosporine—psoriasis	0.0218	0.0476	CbGbCtD
Galantamine—CYP3A4—Cholecalciferol—psoriasis	0.0211	0.046	CbGbCtD
Galantamine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0183	0.0399	CbGbCtD
Galantamine—CYP3A4—Triamcinolone—psoriasis	0.0183	0.0399	CbGbCtD
Galantamine—CYP3A4—Betamethasone—psoriasis	0.0157	0.0342	CbGbCtD
Galantamine—CYP3A4—Prednisolone—psoriasis	0.0155	0.0338	CbGbCtD
Galantamine—CYP3A4—Hydrocortisone—psoriasis	0.0147	0.032	CbGbCtD
Galantamine—CYP3A4—Prednisone—psoriasis	0.0146	0.0319	CbGbCtD
Galantamine—CYP2D6—Dexamethasone—psoriasis	0.0144	0.0313	CbGbCtD
Galantamine—CYP3A4—Cyclosporine—psoriasis	0.0139	0.0302	CbGbCtD
Galantamine—CYP3A4—Dexamethasone—psoriasis	0.00914	0.0199	CbGbCtD
Galantamine—CHRNA3—skin epidermis—psoriasis	0.00675	0.194	CbGeAlD
Galantamine—CHRNA7—skin epidermis—psoriasis	0.00441	0.127	CbGeAlD
Galantamine—CHRNA6—skin of body—psoriasis	0.00376	0.108	CbGeAlD
Galantamine—CHRNG—tendon—psoriasis	0.0027	0.0773	CbGeAlD
Galantamine—CHRNB4—tendon—psoriasis	0.0026	0.0745	CbGeAlD
Galantamine—CHRNA10—tendon—psoriasis	0.00229	0.0656	CbGeAlD
Galantamine—CHRND—tendon—psoriasis	0.00214	0.0613	CbGeAlD
Galantamine—CHRNA3—skin of body—psoriasis	0.00209	0.06	CbGeAlD
Galantamine—CHRNA1—tendon—psoriasis	0.00178	0.0512	CbGeAlD
Galantamine—CHRNB2—tendon—psoriasis	0.00164	0.0471	CbGeAlD
Galantamine—CHRNB1—tendon—psoriasis	0.00138	0.0395	CbGeAlD
Galantamine—CHRNA7—skin of body—psoriasis	0.00137	0.0392	CbGeAlD
Galantamine—ACHE—tendon—psoriasis	0.00119	0.0343	CbGeAlD
Galantamine—BCHE—skin of body—psoriasis	0.000771	0.0221	CbGeAlD
Galantamine—Vertigo—Dexamethasone—psoriasis	0.000242	0.000477	CcSEcCtD
Galantamine—Syncope—Betamethasone—psoriasis	0.000241	0.000477	CcSEcCtD
Galantamine—Syncope—Dexamethasone—psoriasis	0.000241	0.000477	CcSEcCtD
Galantamine—Constipation—Mycophenolate mofetil—psoriasis	0.000241	0.000477	CcSEcCtD
Galantamine—Arrhythmia—Prednisone—psoriasis	0.00024	0.000475	CcSEcCtD
Galantamine—Hypotension—Hydrocortisone—psoriasis	0.00024	0.000474	CcSEcCtD
Galantamine—Haematuria—Methotrexate—psoriasis	0.000239	0.000472	CcSEcCtD
Galantamine—Feeling abnormal—Cyclosporine—psoriasis	0.000238	0.000471	CcSEcCtD
Galantamine—Shock—Triamcinolone—psoriasis	0.000238	0.00047	CcSEcCtD
Galantamine—Insomnia—Prednisolone—psoriasis	0.000238	0.00047	CcSEcCtD
Galantamine—Hepatobiliary disease—Methotrexate—psoriasis	0.000237	0.000468	CcSEcCtD
Galantamine—Gastrointestinal pain—Cyclosporine—psoriasis	0.000236	0.000467	CcSEcCtD
Galantamine—Loss of consciousness—Betamethasone—psoriasis	0.000236	0.000467	CcSEcCtD
Galantamine—Loss of consciousness—Dexamethasone—psoriasis	0.000236	0.000467	CcSEcCtD
Galantamine—Dizziness—Mycophenolic acid—psoriasis	0.000236	0.000467	CcSEcCtD
Galantamine—Epistaxis—Methotrexate—psoriasis	0.000236	0.000467	CcSEcCtD
Galantamine—Paraesthesia—Prednisolone—psoriasis	0.000236	0.000467	CcSEcCtD
Galantamine—Tachycardia—Triamcinolone—psoriasis	0.000236	0.000467	CcSEcCtD
Galantamine—Mental disorder—Prednisone—psoriasis	0.000236	0.000466	CcSEcCtD
Galantamine—Malnutrition—Prednisone—psoriasis	0.000234	0.000463	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000234	0.000463	CcSEcCtD
Galantamine—Hyperhidrosis—Triamcinolone—psoriasis	0.000234	0.000462	CcSEcCtD
Galantamine—Convulsion—Dexamethasone—psoriasis	0.000233	0.00046	CcSEcCtD
Galantamine—Convulsion—Betamethasone—psoriasis	0.000233	0.00046	CcSEcCtD
Galantamine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000232	0.000459	CcSEcCtD
Galantamine—Insomnia—Hydrocortisone—psoriasis	0.000232	0.000459	CcSEcCtD
Galantamine—Hypertension—Betamethasone—psoriasis	0.000232	0.000459	CcSEcCtD
Galantamine—Hypertension—Dexamethasone—psoriasis	0.000232	0.000459	CcSEcCtD
Galantamine—Paraesthesia—Hydrocortisone—psoriasis	0.000231	0.000456	CcSEcCtD
Galantamine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000231	0.000456	CcSEcCtD
Galantamine—Myalgia—Dexamethasone—psoriasis	0.000229	0.000452	CcSEcCtD
Galantamine—Myalgia—Betamethasone—psoriasis	0.000229	0.000452	CcSEcCtD
Galantamine—Abdominal pain—Cyclosporine—psoriasis	0.000229	0.000452	CcSEcCtD
Galantamine—Body temperature increased—Cyclosporine—psoriasis	0.000229	0.000452	CcSEcCtD
Galantamine—Anxiety—Betamethasone—psoriasis	0.000228	0.000451	CcSEcCtD
Galantamine—Anxiety—Dexamethasone—psoriasis	0.000228	0.000451	CcSEcCtD
Galantamine—Vomiting—Mycophenolic acid—psoriasis	0.000227	0.000449	CcSEcCtD
Galantamine—Discomfort—Betamethasone—psoriasis	0.000226	0.000447	CcSEcCtD
Galantamine—Discomfort—Dexamethasone—psoriasis	0.000226	0.000447	CcSEcCtD
Galantamine—Dyspepsia—Hydrocortisone—psoriasis	0.000226	0.000447	CcSEcCtD
Galantamine—Haemoglobin—Methotrexate—psoriasis	0.000226	0.000447	CcSEcCtD
Galantamine—Rash—Mycophenolic acid—psoriasis	0.000225	0.000445	CcSEcCtD
Galantamine—Dermatitis—Mycophenolic acid—psoriasis	0.000225	0.000445	CcSEcCtD
Galantamine—Haemorrhage—Methotrexate—psoriasis	0.000225	0.000444	CcSEcCtD
Galantamine—Hepatitis—Methotrexate—psoriasis	0.000225	0.000444	CcSEcCtD
Galantamine—Headache—Mycophenolic acid—psoriasis	0.000224	0.000442	CcSEcCtD
Galantamine—Decreased appetite—Hydrocortisone—psoriasis	0.000223	0.000441	CcSEcCtD
Galantamine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000223	0.00044	CcSEcCtD
Galantamine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000223	0.00044	CcSEcCtD
Galantamine—Urinary tract disorder—Methotrexate—psoriasis	0.000222	0.000439	CcSEcCtD
Galantamine—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000222	0.000438	CcSEcCtD
Galantamine—Fatigue—Hydrocortisone—psoriasis	0.000221	0.000438	CcSEcCtD
Galantamine—Vision blurred—Prednisone—psoriasis	0.000221	0.000436	CcSEcCtD
Galantamine—Urethral disorder—Methotrexate—psoriasis	0.00022	0.000436	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.00022	0.000435	CcSEcCtD
Galantamine—Insomnia—Triamcinolone—psoriasis	0.000219	0.000432	CcSEcCtD
Galantamine—Ill-defined disorder—Prednisone—psoriasis	0.000217	0.000429	CcSEcCtD
Galantamine—Paraesthesia—Triamcinolone—psoriasis	0.000217	0.000429	CcSEcCtD
Galantamine—Feeling abnormal—Prednisolone—psoriasis	0.000217	0.000428	CcSEcCtD
Galantamine—Visual impairment—Methotrexate—psoriasis	0.000217	0.000428	CcSEcCtD
Galantamine—Anaemia—Prednisone—psoriasis	0.000216	0.000428	CcSEcCtD
Galantamine—Shock—Betamethasone—psoriasis	0.000216	0.000427	CcSEcCtD
Galantamine—Shock—Dexamethasone—psoriasis	0.000216	0.000427	CcSEcCtD
Galantamine—Nervous system disorder—Dexamethasone—psoriasis	0.000215	0.000425	CcSEcCtD
Galantamine—Nervous system disorder—Betamethasone—psoriasis	0.000215	0.000425	CcSEcCtD
Galantamine—Agitation—Prednisone—psoriasis	0.000215	0.000425	CcSEcCtD
Galantamine—Thrombocytopenia—Dexamethasone—psoriasis	0.000215	0.000425	CcSEcCtD
Galantamine—Thrombocytopenia—Betamethasone—psoriasis	0.000215	0.000425	CcSEcCtD
Galantamine—Tachycardia—Betamethasone—psoriasis	0.000214	0.000423	CcSEcCtD
Galantamine—Tachycardia—Dexamethasone—psoriasis	0.000214	0.000423	CcSEcCtD
Galantamine—Hypersensitivity—Cyclosporine—psoriasis	0.000213	0.000421	CcSEcCtD
Galantamine—Dyspepsia—Triamcinolone—psoriasis	0.000213	0.000421	CcSEcCtD
Galantamine—Nausea—Mycophenolic acid—psoriasis	0.000212	0.000419	CcSEcCtD
Galantamine—Hyperhidrosis—Dexamethasone—psoriasis	0.000212	0.000419	CcSEcCtD
Galantamine—Hyperhidrosis—Betamethasone—psoriasis	0.000212	0.000419	CcSEcCtD
Galantamine—Feeling abnormal—Hydrocortisone—psoriasis	0.000212	0.000418	CcSEcCtD
Galantamine—Malaise—Prednisone—psoriasis	0.000211	0.000417	CcSEcCtD
Galantamine—Vertigo—Prednisone—psoriasis	0.00021	0.000416	CcSEcCtD
Galantamine—Eye disorder—Methotrexate—psoriasis	0.00021	0.000415	CcSEcCtD
Galantamine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.00021	0.000415	CcSEcCtD
Galantamine—Syncope—Prednisone—psoriasis	0.00021	0.000415	CcSEcCtD
Galantamine—Tinnitus—Methotrexate—psoriasis	0.00021	0.000414	CcSEcCtD
Galantamine—Anorexia—Dexamethasone—psoriasis	0.000209	0.000413	CcSEcCtD
Galantamine—Anorexia—Betamethasone—psoriasis	0.000209	0.000413	CcSEcCtD
Galantamine—Cardiac disorder—Methotrexate—psoriasis	0.000209	0.000412	CcSEcCtD
Galantamine—Fatigue—Triamcinolone—psoriasis	0.000209	0.000412	CcSEcCtD
Galantamine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000208	0.000411	CcSEcCtD
Galantamine—Asthenia—Cyclosporine—psoriasis	0.000207	0.00041	CcSEcCtD
Galantamine—Loss of consciousness—Prednisone—psoriasis	0.000206	0.000407	CcSEcCtD
Galantamine—Hypotension—Dexamethasone—psoriasis	0.000205	0.000405	CcSEcCtD
Galantamine—Hypotension—Betamethasone—psoriasis	0.000205	0.000405	CcSEcCtD
Galantamine—Angiopathy—Methotrexate—psoriasis	0.000204	0.000403	CcSEcCtD
Galantamine—Immune system disorder—Methotrexate—psoriasis	0.000203	0.000401	CcSEcCtD
Galantamine—Body temperature increased—Hydrocortisone—psoriasis	0.000203	0.000401	CcSEcCtD
Galantamine—Abdominal pain—Hydrocortisone—psoriasis	0.000203	0.000401	CcSEcCtD
Galantamine—Convulsion—Prednisone—psoriasis	0.000203	0.000401	CcSEcCtD
Galantamine—Asthenia—Mycophenolate mofetil—psoriasis	0.000202	0.0004	CcSEcCtD
Galantamine—Hypertension—Prednisone—psoriasis	0.000202	0.0004	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.0002	0.000395	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.0002	0.000395	CcSEcCtD
Galantamine—Arthralgia—Prednisone—psoriasis	0.000199	0.000394	CcSEcCtD
Galantamine—Myalgia—Prednisone—psoriasis	0.000199	0.000394	CcSEcCtD
Galantamine—Feeling abnormal—Triamcinolone—psoriasis	0.000199	0.000394	CcSEcCtD
Galantamine—Anxiety—Prednisone—psoriasis	0.000199	0.000393	CcSEcCtD
Galantamine—Insomnia—Betamethasone—psoriasis	0.000199	0.000392	CcSEcCtD
Galantamine—Insomnia—Dexamethasone—psoriasis	0.000199	0.000392	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000198	0.000391	CcSEcCtD
Galantamine—Diarrhoea—Cyclosporine—psoriasis	0.000198	0.000391	CcSEcCtD
Galantamine—Paraesthesia—Betamethasone—psoriasis	0.000197	0.000389	CcSEcCtD
Galantamine—Paraesthesia—Dexamethasone—psoriasis	0.000197	0.000389	CcSEcCtD
Galantamine—Discomfort—Prednisone—psoriasis	0.000197	0.000389	CcSEcCtD
Galantamine—Mental disorder—Methotrexate—psoriasis	0.000197	0.000389	CcSEcCtD
Galantamine—Malnutrition—Methotrexate—psoriasis	0.000196	0.000387	CcSEcCtD
Galantamine—Hypersensitivity—Prednisolone—psoriasis	0.000194	0.000383	CcSEcCtD
Galantamine—Dyspepsia—Betamethasone—psoriasis	0.000193	0.000382	CcSEcCtD
Galantamine—Dyspepsia—Dexamethasone—psoriasis	0.000193	0.000382	CcSEcCtD
Galantamine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000193	0.000381	CcSEcCtD
Galantamine—Dysgeusia—Methotrexate—psoriasis	0.000192	0.000379	CcSEcCtD
Galantamine—Body temperature increased—Triamcinolone—psoriasis	0.000191	0.000378	CcSEcCtD
Galantamine—Dizziness—Cyclosporine—psoriasis	0.000191	0.000378	CcSEcCtD
Galantamine—Decreased appetite—Betamethasone—psoriasis	0.000191	0.000377	CcSEcCtD
Galantamine—Decreased appetite—Dexamethasone—psoriasis	0.000191	0.000377	CcSEcCtD
Galantamine—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000189	0.000374	CcSEcCtD
Galantamine—Gastrointestinal disorder—Betamethasone—psoriasis	0.000189	0.000374	CcSEcCtD
Galantamine—Back pain—Methotrexate—psoriasis	0.000189	0.000374	CcSEcCtD
Galantamine—Hypersensitivity—Hydrocortisone—psoriasis	0.000189	0.000374	CcSEcCtD
Galantamine—Fatigue—Dexamethasone—psoriasis	0.000189	0.000374	CcSEcCtD
Galantamine—Fatigue—Betamethasone—psoriasis	0.000189	0.000374	CcSEcCtD
Galantamine—Shock—Prednisone—psoriasis	0.000188	0.000372	CcSEcCtD
Galantamine—Nervous system disorder—Prednisone—psoriasis	0.000187	0.00037	CcSEcCtD
Galantamine—Tachycardia—Prednisone—psoriasis	0.000187	0.000369	CcSEcCtD
Galantamine—Dizziness—Mycophenolate mofetil—psoriasis	0.000186	0.000368	CcSEcCtD
Galantamine—Skin disorder—Prednisone—psoriasis	0.000186	0.000367	CcSEcCtD
Galantamine—Hyperhidrosis—Prednisone—psoriasis	0.000185	0.000365	CcSEcCtD
Galantamine—Vision blurred—Methotrexate—psoriasis	0.000184	0.000365	CcSEcCtD
Galantamine—Asthenia—Hydrocortisone—psoriasis	0.000184	0.000364	CcSEcCtD
Galantamine—Vomiting—Cyclosporine—psoriasis	0.000184	0.000363	CcSEcCtD
Galantamine—Rash—Cyclosporine—psoriasis	0.000182	0.00036	CcSEcCtD
Galantamine—Anorexia—Prednisone—psoriasis	0.000182	0.00036	CcSEcCtD
Galantamine—Dermatitis—Cyclosporine—psoriasis	0.000182	0.00036	CcSEcCtD
Galantamine—Ill-defined disorder—Methotrexate—psoriasis	0.000182	0.000359	CcSEcCtD
Galantamine—Headache—Cyclosporine—psoriasis	0.000181	0.000358	CcSEcCtD
Galantamine—Anaemia—Methotrexate—psoriasis	0.000181	0.000357	CcSEcCtD
Galantamine—Feeling abnormal—Dexamethasone—psoriasis	0.000181	0.000357	CcSEcCtD
Galantamine—Feeling abnormal—Betamethasone—psoriasis	0.000181	0.000357	CcSEcCtD
Galantamine—Gastrointestinal pain—Dexamethasone—psoriasis	0.000179	0.000355	CcSEcCtD
Galantamine—Gastrointestinal pain—Betamethasone—psoriasis	0.000179	0.000355	CcSEcCtD
Galantamine—Vomiting—Mycophenolate mofetil—psoriasis	0.000179	0.000354	CcSEcCtD
Galantamine—Hypersensitivity—Triamcinolone—psoriasis	0.000178	0.000352	CcSEcCtD
Galantamine—Rash—Mycophenolate mofetil—psoriasis	0.000178	0.000351	CcSEcCtD
Galantamine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000178	0.000351	CcSEcCtD
Galantamine—Headache—Mycophenolate mofetil—psoriasis	0.000177	0.000349	CcSEcCtD
Galantamine—Malaise—Methotrexate—psoriasis	0.000177	0.000349	CcSEcCtD
Galantamine—Vertigo—Methotrexate—psoriasis	0.000176	0.000347	CcSEcCtD
Galantamine—Diarrhoea—Hydrocortisone—psoriasis	0.000176	0.000347	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Prednisone—psoriasis	0.000174	0.000344	CcSEcCtD
Galantamine—Dizziness—Prednisolone—psoriasis	0.000174	0.000344	CcSEcCtD
Galantamine—Asthenia—Triamcinolone—psoriasis	0.000174	0.000343	CcSEcCtD
Galantamine—Abdominal pain—Dexamethasone—psoriasis	0.000174	0.000343	CcSEcCtD
Galantamine—Body temperature increased—Betamethasone—psoriasis	0.000174	0.000343	CcSEcCtD
Galantamine—Body temperature increased—Dexamethasone—psoriasis	0.000174	0.000343	CcSEcCtD
Galantamine—Abdominal pain—Betamethasone—psoriasis	0.000174	0.000343	CcSEcCtD
Galantamine—Insomnia—Prednisone—psoriasis	0.000173	0.000342	CcSEcCtD
Galantamine—Nausea—Cyclosporine—psoriasis	0.000172	0.000339	CcSEcCtD
Galantamine—Paraesthesia—Prednisone—psoriasis	0.000172	0.000339	CcSEcCtD
Galantamine—Cough—Methotrexate—psoriasis	0.000171	0.000338	CcSEcCtD
Galantamine—Dizziness—Hydrocortisone—psoriasis	0.00017	0.000336	CcSEcCtD
Galantamine—Convulsion—Methotrexate—psoriasis	0.00017	0.000335	CcSEcCtD
Galantamine—Dyspepsia—Prednisone—psoriasis	0.000168	0.000332	CcSEcCtD
Galantamine—Nausea—Mycophenolate mofetil—psoriasis	0.000168	0.000331	CcSEcCtD
Galantamine—Chest pain—Methotrexate—psoriasis	0.000167	0.000329	CcSEcCtD
Galantamine—Myalgia—Methotrexate—psoriasis	0.000167	0.000329	CcSEcCtD
Galantamine—Arthralgia—Methotrexate—psoriasis	0.000167	0.000329	CcSEcCtD
Galantamine—Decreased appetite—Prednisone—psoriasis	0.000166	0.000328	CcSEcCtD
Galantamine—Rash—Prednisolone—psoriasis	0.000166	0.000328	CcSEcCtD
Galantamine—Dermatitis—Prednisolone—psoriasis	0.000166	0.000327	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000165	0.000327	CcSEcCtD
Galantamine—Fatigue—Prednisone—psoriasis	0.000165	0.000326	CcSEcCtD
Galantamine—Headache—Prednisolone—psoriasis	0.000165	0.000326	CcSEcCtD
Galantamine—Discomfort—Methotrexate—psoriasis	0.000165	0.000325	CcSEcCtD
Galantamine—Constipation—Prednisone—psoriasis	0.000163	0.000323	CcSEcCtD
Galantamine—Vomiting—Hydrocortisone—psoriasis	0.000163	0.000323	CcSEcCtD
Galantamine—Rash—Hydrocortisone—psoriasis	0.000162	0.00032	CcSEcCtD
Galantamine—Dermatitis—Hydrocortisone—psoriasis	0.000162	0.00032	CcSEcCtD
Galantamine—Confusional state—Methotrexate—psoriasis	0.000161	0.000318	CcSEcCtD
Galantamine—Headache—Hydrocortisone—psoriasis	0.000161	0.000318	CcSEcCtD
Galantamine—Dizziness—Triamcinolone—psoriasis	0.00016	0.000316	CcSEcCtD
Galantamine—Feeling abnormal—Prednisone—psoriasis	0.000158	0.000311	CcSEcCtD
Galantamine—Asthenia—Dexamethasone—psoriasis	0.000157	0.000311	CcSEcCtD
Galantamine—Asthenia—Betamethasone—psoriasis	0.000157	0.000311	CcSEcCtD
Galantamine—Nervous system disorder—Methotrexate—psoriasis	0.000157	0.00031	CcSEcCtD
Galantamine—Thrombocytopenia—Methotrexate—psoriasis	0.000156	0.000309	CcSEcCtD
Galantamine—Gastrointestinal pain—Prednisone—psoriasis	0.000156	0.000309	CcSEcCtD
Galantamine—Nausea—Prednisolone—psoriasis	0.000156	0.000309	CcSEcCtD
Galantamine—Skin disorder—Methotrexate—psoriasis	0.000155	0.000307	CcSEcCtD
Galantamine—Hyperhidrosis—Methotrexate—psoriasis	0.000154	0.000305	CcSEcCtD
Galantamine—Vomiting—Triamcinolone—psoriasis	0.000154	0.000304	CcSEcCtD
Galantamine—Nausea—Hydrocortisone—psoriasis	0.000153	0.000302	CcSEcCtD
Galantamine—Rash—Triamcinolone—psoriasis	0.000153	0.000301	CcSEcCtD
Galantamine—Dermatitis—Triamcinolone—psoriasis	0.000152	0.000301	CcSEcCtD
Galantamine—Anorexia—Methotrexate—psoriasis	0.000152	0.000301	CcSEcCtD
Galantamine—Headache—Triamcinolone—psoriasis	0.000152	0.000299	CcSEcCtD
Galantamine—Abdominal pain—Prednisone—psoriasis	0.000151	0.000299	CcSEcCtD
Galantamine—Body temperature increased—Prednisone—psoriasis	0.000151	0.000299	CcSEcCtD
Galantamine—Diarrhoea—Dexamethasone—psoriasis	0.00015	0.000297	CcSEcCtD
Galantamine—Diarrhoea—Betamethasone—psoriasis	0.00015	0.000297	CcSEcCtD
Galantamine—Hypotension—Methotrexate—psoriasis	0.000149	0.000295	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000146	0.000288	CcSEcCtD
Galantamine—Dizziness—Betamethasone—psoriasis	0.000145	0.000287	CcSEcCtD
Galantamine—Dizziness—Dexamethasone—psoriasis	0.000145	0.000287	CcSEcCtD
Galantamine—Insomnia—Methotrexate—psoriasis	0.000144	0.000286	CcSEcCtD
Galantamine—Nausea—Triamcinolone—psoriasis	0.000144	0.000284	CcSEcCtD
Galantamine—Paraesthesia—Methotrexate—psoriasis	0.000143	0.000283	CcSEcCtD
Galantamine—Somnolence—Methotrexate—psoriasis	0.000142	0.000281	CcSEcCtD
Galantamine—Hypersensitivity—Prednisone—psoriasis	0.000141	0.000278	CcSEcCtD
Galantamine—Dyspepsia—Methotrexate—psoriasis	0.000141	0.000278	CcSEcCtD
Galantamine—Vomiting—Dexamethasone—psoriasis	0.00014	0.000276	CcSEcCtD
Galantamine—Vomiting—Betamethasone—psoriasis	0.00014	0.000276	CcSEcCtD
Galantamine—Decreased appetite—Methotrexate—psoriasis	0.000139	0.000274	CcSEcCtD
Galantamine—Rash—Dexamethasone—psoriasis	0.000138	0.000273	CcSEcCtD
Galantamine—Rash—Betamethasone—psoriasis	0.000138	0.000273	CcSEcCtD
Galantamine—Dermatitis—Betamethasone—psoriasis	0.000138	0.000273	CcSEcCtD
Galantamine—Dermatitis—Dexamethasone—psoriasis	0.000138	0.000273	CcSEcCtD
Galantamine—Gastrointestinal disorder—Methotrexate—psoriasis	0.000138	0.000273	CcSEcCtD
Galantamine—Fatigue—Methotrexate—psoriasis	0.000138	0.000272	CcSEcCtD
Galantamine—Headache—Betamethasone—psoriasis	0.000138	0.000272	CcSEcCtD
Galantamine—Headache—Dexamethasone—psoriasis	0.000138	0.000272	CcSEcCtD
Galantamine—Asthenia—Prednisone—psoriasis	0.000137	0.000271	CcSEcCtD
Galantamine—Feeling abnormal—Methotrexate—psoriasis	0.000132	0.00026	CcSEcCtD
Galantamine—Diarrhoea—Prednisone—psoriasis	0.000131	0.000258	CcSEcCtD
Galantamine—Gastrointestinal pain—Methotrexate—psoriasis	0.000131	0.000258	CcSEcCtD
Galantamine—Nausea—Dexamethasone—psoriasis	0.00013	0.000258	CcSEcCtD
Galantamine—Nausea—Betamethasone—psoriasis	0.00013	0.000258	CcSEcCtD
Galantamine—Dizziness—Prednisone—psoriasis	0.000126	0.00025	CcSEcCtD
Galantamine—Body temperature increased—Methotrexate—psoriasis	0.000126	0.00025	CcSEcCtD
Galantamine—Abdominal pain—Methotrexate—psoriasis	0.000126	0.00025	CcSEcCtD
Galantamine—Vomiting—Prednisone—psoriasis	0.000122	0.00024	CcSEcCtD
Galantamine—Rash—Prednisone—psoriasis	0.000121	0.000238	CcSEcCtD
Galantamine—Dermatitis—Prednisone—psoriasis	0.00012	0.000238	CcSEcCtD
Galantamine—Headache—Prednisone—psoriasis	0.00012	0.000237	CcSEcCtD
Galantamine—Hypersensitivity—Methotrexate—psoriasis	0.000118	0.000233	CcSEcCtD
Galantamine—Asthenia—Methotrexate—psoriasis	0.000115	0.000226	CcSEcCtD
Galantamine—Nausea—Prednisone—psoriasis	0.000114	0.000224	CcSEcCtD
Galantamine—Diarrhoea—Methotrexate—psoriasis	0.000109	0.000216	CcSEcCtD
Galantamine—Dizziness—Methotrexate—psoriasis	0.000106	0.000209	CcSEcCtD
Galantamine—Vomiting—Methotrexate—psoriasis	0.000102	0.000201	CcSEcCtD
Galantamine—Rash—Methotrexate—psoriasis	0.000101	0.000199	CcSEcCtD
Galantamine—Dermatitis—Methotrexate—psoriasis	0.000101	0.000199	CcSEcCtD
Galantamine—Headache—Methotrexate—psoriasis	0.0001	0.000198	CcSEcCtD
Galantamine—Nausea—Methotrexate—psoriasis	9.49e-05	0.000187	CcSEcCtD
